Clinical Trial Update: Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy

View source ↗

Summary

The completed trial evaluated changes in visual acuity in patients with diabetic macular edema who started treatment with an approved anti-VEGF therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Snippet

Sponsor: Bayer | Conditions: Ophthalmology, Macular Edema | Status: COMPLETED